FDA Denies Marketing of Suorin and blu PLUS+ E-Cigarette Products

From Food and Drug Administration Center for Tobacco Products

On January 19, FDA issued marketing denial orders (MDOs) to Shenzhen Youme Information Technology Co. Ltd. for two Suorin brand e-cigarette products and to Fontem US, LLC for their blu PLUS+ brand e-cigarette products.  The companies must not market or distribute these products in the United States or they risk FDA enforcement action.  The companies may submit new applications for the products that are subject to these MDOs.

“Thorough scientific review of tobacco products applications is a key pillar of FDA’s comprehensive regulatory approach,” said Brian King., Ph.D., Director of FDA’s Center for Tobacco Products.  “It is the applicant’s responsibility to ensure that sufficient scientific evidence is included in an application to meet the necessary public health standard required by law.  In these cases, such evidence was lacking.”



Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.


The National Institutes of Health Announces Undergraduate Student Scholarships to attend the 2024 AAIP 52nd Annual Meeting and National Health Conference | LEARN MORE AND REGISTER

AAIP 52nd Annual Meeting & Health Conference | LEARN MORE

WEBINAR:  Pediatric, Adolescent, and Young Adult Cancer Survivorship ECHO from American Cancer Society | LEARN MORE AND REGISTER

2025 National Conference on Tobacco or Health; presented by National Network of Public Health Institutes; Chicago, Illinois | LEARN MORE AND REGISTER